OncoSec Blog OncoSec to Present at the Cantor 2019 Global Healthcare Conference

SAN DIEGO and PENNINGTON, N.J., Sept. 26, 2019 /PRNewswire/ - OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, President and Chief Executive Officer of OncoSec, will present a company overview at the Cantor 2019 Global Healthcare Conference on Thursday, October 3, 2019, at 2:25 p.m. [...]